Duplicate Document
This document appears to be a copy. The original version is:
EFTA Document EFTA01493409Case File
efta-efta01493409DOJ Data Set 10CorrespondenceEFTA Document EFTA01493409
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01493409
Pages
0
Persons
0
Integrity
Loading PDF viewer...
Summary
Ask AI About This Document
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
FINANCIAL TRUST COMPANY INC ACCT.
For the Period 9/1/12 to 9/30/12
Note
P indicates position adjusted for Pending Trade Activity.
Unrealized GainiLoss is shown as "N A" in cases where we do not have appropriate cost information for all lax lots comprising the position. Please contact your J P Morgan team for additional
information.
Equity Detail
Adjusted Tax Cost
Unrealized
Est. Annual Inc
Pike
Quantity
Value
Original Cost
Gain/Loss
Accrued Div.
Yield
US Large Cap Equity
ARIAD PHARMACEUTICALS INC
24.21
16,535.000
400,312.35
251,475.52
148,836.83
04033A-10-0 ARIA
BIOGEN IDEC INC
09062X-10-3 BIIB
FACEBOOK INC-A
30303M-10-2 FB
149.21
2,095.000
312.594.95
250,454.95
62,140.00
21.66
17.500 003
379.050.00
665,000 00
(285,950.00)
Total US Large Cap Equity
US Small Cap Equity
P PENNANTPARK INVESTMENT CORP
708062-10-4 PNNT
10 61
$1,091,967.30
81,166,930.47
(574.973.17)
30.00
0.00%
0.00
10 56 %
US Small/Mid Cap Equity
P CASELLA WASTE SYSTEMS INC
4.27
0.00
CL A
147448-10-4 CWST
JP Morgan
Account
Page 5 of 36
Consolidated Statement Page 9
Confidential Treatment Requested by JPMorgan
Chase
CONFIDENTIAL
JPM-SDNY-000 16266
SDNY_GM_00285464
EFTA01493409
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.